Evaluation of saroglitazar efficacy and safety in management of metabolic dysfunction associated steatotic liver disease: a single centre, open label, real world, observational study
Saved in:
Published in | Journal of clinical and experimental hepatology Vol. 14; p. 102235 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
2024
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 0973-6883 |
---|---|
DOI: | 10.1016/j.jceh.2024.102235 |